Insulin Glargine-Aglr
1 NDC across 1 manufacturer|0 Generic,1 Brand
Insulin Glargine-Aglr is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $586K on Insulin Glargine-Aglr across 6,554 claims for 2,344 beneficiaries.
Insulin Glargine-Aglr is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $5.92 to $5.92 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$5.92 – $5.92
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing INSULIN GLARGINE-AGLR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
REZVOGLAR 100 UNIT/ML KWIKPEN | $5.9196 per ML | +0.02% |
Frequently Asked Questions
What is Insulin Glargine-Aglr used to treat?
Insulin Glargine-Aglr is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Insulin Glargine-Aglr?
In 2024, Medicare Part D spent $586K on Insulin Glargine-Aglr across 6,554 claims for 2,344 beneficiaries.
How many Insulin Glargine-Aglr products are on the market?
The Insulin Glargine-Aglr drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Insulin Glargine-Aglr?
NADAC reference prices for Insulin Glargine-Aglr range from $5.9196 to $5.9196 per ML.
Which manufacturers make Insulin Glargine-Aglr?
1 manufacturer lists Insulin Glargine-Aglr in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (1).
How has the price of Insulin Glargine-Aglr changed recently?
Over the past 7 days, 1 Insulin Glargine-Aglr NDC rose and 0 fell, with a market-wide average change of +0.0%.